Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
AMRX logo

AMRX

NGS
Amneal Pharmaceuticals Inc.
HealthcareDrug Manufacturers - Specialty & Generic
Watchlists:
Last updated: Sunday 13th July 2025
8.33
-0.06 (-0.72%)
Prev Close:8.39
Open:8.31
Bid:8.21
Ask:8.34
52 Week Range
6.50
9.48
Volume:1,797,861
Mkt Cap:2,586 M
Price Target
$9.58
+15.0%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

AMRX - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Invalid date
Accretion On Preferred Stock438000.01 M-375 M
Accrued Preferred Stock Dividends-149 M168 M
Acquisition Expense700000.08 M9 M16 M
Depreciation And Amortization63 M66 M68 M61 M60 M63 M-64 M-42 M
Fees-2 M
Gain On Sale Of Security-3 M-29 M
Gains Loss On Disposal Of Discontinued Operations123000.07 M
General And Administrative Expense476 M430 M400 M366 M327 M290 M-18 M-17 M
Gross Profit Margin (profit Margin After CGS)1,020 M821 M785 M769 M628 M479 M716 M526 M
Impairment Of Capital Assets31 M13 M710000.03 M47 M39 M-4 M
Interest Expense Non Operating211 M158 M136 M146 M5 M-1 M
Interest Expense Operating2 M
Minority Interests-43 M-35 M125 M-10 M22 M242 M33 M-2 M
Misc Other Special Charges12 M-33 M18 M15 M3 M194 M-19 M-3 M
Net Income (loss)-117 M-84 M-130 M11 M91 M-362 M-22 M169 M
Net Income Common Stockholders-117 M-84 M-130 M11 M91 M-362 M-23 M1 M
Net Income Continuous Operations-74 M-49 M-255 M11 M91 M-362 M-22 M169 M
Net Income Discontinuous Operations123000.07 M
Net Income From Other Gains Losses149 M
Net Non Operating Interest Income Expense-259 M-211 M159 M-136 M-146 M-168 M-142 M-70 M
Non Recurring Operation Expense97 M2 M270 M25 M6 M12 M-20 M-9 M
Operating Income249 M204 M-95 M153 M91 M-249 M56 M236 M
Operating Income Before Depreciation (EBITDA)210 M201 M-90 M401 M346 M35 M-47 M221 M
Operating Expense667 M592 M596 M562 M508 M475 M660 M290 M
Other Gand A476 M430 M400 M366 M327 M290 M-18 M-17 M
Other Impairment Of Capital Assets24 M1000000.02 M
Other Operating Expenses-1 M398000.08 M11 M14 M16 M
Otherunder Preferred Stock Dividend438000.01 M168 M
Preferred Stock Dividends438000.01 M168 M
Rent And Landing Fees-18 M-17 M
Research Expense191 M164 M196 M202 M180 M188 M194 M171 M
Restructring And Mn A Income2 M2 M1 M2 M2 M34 M56 M
Salaries And Wages32 M-13 M-9 M-16 M222 M9 M
Selling And Marketing Expense228 M109 M
Selling Expense228 M109 M
Total Income Available For Interest Expense (EBIT)-55 M-40 M-90 M168 M110 M-216 M-201 M170 M
Total Revenues2,794 M2,394 M2,212 M2,116 M2,027 M1,753 M1,655 M1,034 M
Total Expenses2,441 M2,166 M2,023 M1,864 M1,838 M1,623 M-279 M-218 M
Total Revenue2,794 M2,394 M2,212 M2,094 M1,993 M1,626 M1,663 M1,034 M
Amord737 M895 M1,096 M1,172 M1,305 M1,389 M-73 M-9 M
Avgshs309 M176 M151 M149 M147 M132 M127 M
Avgshsdt309 M176 M151 M152 M149 M136 M
Basiceps-0.38-0.48-0.860.070.62-2.74-0.07
Basicepscont-0.38-0.48-0.860.070.62-2.74
Cor1,774 M1,573 M1,428 M1,325 M1,364 M1,147 M-939 M-507 M
Depamor68 M61 M60 M63 M-64 M-42 M
Dileps-0.38-0.48-0.860.070.61-2.74-0.16
Dilepscont-0.38-0.48-0.860.070.61
Intinc-259 M-211 M-158 M-136 M-146 M-168 M-142 M-71 M
Netincdisc-117 M-84 M-130 M11 M91 M-362 M-22 M169 M
Othincexp-13 M18 M-278 M-15 M-3 M-194 M22 M32 M
Othspecchg-4 M
Pretaxinc-55 M-40 M-248 M31 M-36 M-220 M-203 M171 M
Resdev191 M164 M196 M202 M180 M188 M194 M171 M
Restruct2 M2 M1 M2 M2 M34 M56 M
Sga476 M430 M400 M366 M327 M290 M228 M109 M
Shsout310 M307 M304 M302 M300 M299 M299 M1000.0
Specincchg-99 M-34 M-284 M-28 M-11 M-93 M-76 M9 M
Taxprov19 M9 M7 M11 M-104 M383 M-1 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader